Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04700332 | PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer | recruiting | Phase 2 | 184 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT04834544 | A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care | recruiting | Phase 2 | 75 | Peking University Third HospitalOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT03541928 |
| Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery |
| recruiting |
| Phase 2 |
| 60 |
| The Methodist Hospital Research InstituteOTHER |
| 1 |
| Apr 6, 2021 |
| clinicaltrials |
| NCT03025477 | Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer(CHIMOVIP) | recruiting | Phase 2 | 84 | Groupe Hospitalier Diaconesses Croix Saint-SimonOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT03294889 | ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | recruiting | Phase 1 / Phase 2 | 45 | University Hospital, GenevaOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT04212715 | Prostate SABR With Intra-Prostatic SABR Boost | recruiting | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | recruiting | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT02391051 | Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial(FOKAL-BT) | recruiting | Phase 2 | 50 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT01913106 | HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer | recruiting | Phase 1 / Phase 2 | 25 | The Methodist Hospital Research InstituteOTHER | 1 | Jul 1, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jul 27, 2021source: clinicaltrials